6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
23m ago	Sunrun Prices $584 million Securitization of Residential Solar and Storage Assets
24m ago	Madison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
47m ago	Ultra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
48m ago	GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
48m ago	Rush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

About

Eyepoint Pharmaceuticals Inc (NASDAQ:EYPT) — investor relations, events, news, and company updates on 6ix.

Latest News

EyePoint Reports Fourth Quarter and Full-Year 2025 Financial Results and Highlights Recent Corporate Developments

EyePoint Announces First Patients Dosed in Both Global Phase 3 Clinical Trials of DURAVYU™ for the Treatment of Diabetic Macular Edema

EyePoint to Report Fourth Quarter and Full-Year 2025 Financial Results on March 4, 2026

EyePoint Appoints Michael Campbell as Chief Commercial Officer

EyePoint to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Financials

Revenue

$31.37 M

Market Cap

$1.12 B

EPS

-3.17

Community Chat

Ask AI